Versant Vantage II, L.P. insider trades: LENZ Therapeutics (LENZ) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Versant Vantage II, L.P. reports to the SEC
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | LENZ | ↓ Sell | 132,944 | $46.01 | $6.1M | Direct | Oct 2, 2025 (2d) |
| Sep 30, 2025 | LENZ | ↓ Sell | 92,030 | $46.01 | $4.2M | Indirect | Oct 2, 2025 (2d) |
| Sep 18, 2025 | LENZ | ↓ Sell | 90,654 | $42.23 | $3.8M | Direct | Sep 22, 2025 (4d) |
| Sep 18, 2025 | LENZ | ↓ Sell | 44,650 | $42.23 | $1.9M | Indirect | Sep 22, 2025 (4d) |
| Aug 26, 2025 | LENZ | ↓ Sell | 126,023 | $39.47 | $5.0M | Direct | Aug 26, 2025 (0d) |
| Aug 26, 2025 | LENZ | ↓ Sell | 62,071 | $39.47 | $2.4M | Indirect | Aug 26, 2025 (0d) |
| Aug 18, 2025 | LENZ | ↓ Sell | 175,679 | $39.34 | $6.9M | Direct | Aug 19, 2025 (1d) |
| Aug 18, 2025 | LENZ | ↓ Sell | 85,034 | $39.33 | $3.3M | Indirect | Aug 19, 2025 (1d) |
| Jul 10, 2025 | LENZ | ↓ Sell | 191,376 | $34.00 | $6.5M | Direct | Jul 14, 2025 (4d) |
| Jun 27, 2025 | LENZ | ↓ Sell | 200,000 | $30.46 | $6.1M | Direct | Jul 1, 2025 (4d) |
| Jun 20, 2025 | LENZ | ↓ Sell | 200,877 | $30.15 | $6.1M | Indirect | Jun 20, 2025 (0d) |
| Jun 20, 2025 | LENZ | ↓ Sell | 133,924 | $30.25 | $4.1M | Direct | Jun 20, 2025 (0d) |
| Jun 10, 2025 | LENZ | ↓ Sell | 350,000 | $29.00 | $10.2M | Indirect | Jun 12, 2025 (2d) |
| Aug 12, 2024 | TPST | ↓ Sell | 787,999 | $1.23 | $967K | Direct | Aug 12, 2024 (0d) |
| Jul 25, 2023 | TSBX | ↑ Buy | 197,458 | $12.00 | $2.4M | By Versant Venture Capital V, L.P. | Jul 27, 2023 (2d) |
| Jul 25, 2023 | TSBX | ↑ Buy | 15,028 | $12.00 | $180K | By Versant Venture Capital V (Canada) LP | Jul 27, 2023 (2d) |
| Jul 25, 2023 | TSBX | ↑ Buy | 6,575 | $12.00 | $79K | By Versant Ophthalmic Affiliates Fund I, | Jul 27, 2023 (2d) |
| Jul 25, 2023 | TSBX | ↑ Buy | 5,939 | $12.00 | $71K | By Versant Affiliates Fund V, L.P. | Jul 27, 2023 (2d) |
| Aug 9, 2022 | IPSC | ↓ Sell | 550,000 | $13.03 | $7.2M | Direct | Aug 11, 2022 (2d) |
| Jun 29, 2021 | GRPH | ↑ Buy | 180,000 | $17.00 | $3.1M | Indirect | Jul 1, 2021 (2d) |
| Jun 22, 2021 | IPSC | ↑ Buy | 100,000 | $20.00 | $2.0M | Indirect | Jun 23, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other LENZ insiders
Open-market trades in the last 12 months
About Versant Vantage II, L.P.'s insider trades
Versant Vantage II, L.P. is an insider at LENZ Therapeutics (LENZ). Since Jun 22, 2021, it has reported 6 open-market purchases worth $7.8M and 15 sales worth $74.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (5 filings), conversions (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LENZ insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.